Form 4: Amgen Director Omar Ishrak Reports Acquisition of Common Stock

Director Omar Ishrak reports acquiring Amgen common stock through vested Restricted Stock Units (RSUs) under the company's incentive program.

Summary

• On November 4, 2024, Omar Ishrak, a director of Amgen Inc., acquired 220.8829 shares of Amgen common stock.
• The acquisition was a result of vested Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Director Incentive Program.
• The RSUs vested immediately and are paid in shares of Amgen's common stock on a one-to-one basis.
• The reported transaction increased Ishrak's direct ownership to 5,081.0807 shares, which includes 190 Dividend Equivalents (DEs).
• These DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

Sentiment

Score: 7

Explanation: Director acquiring shares is generally a positive sign, indicating confidence in the company. However, it's a routine transaction related to compensation.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Director share acquisitions are common and are viewed as a sign of confidence in the company's prospects. This transaction is part of standard director compensation and incentive programs.

Key Dates